Wedbush Score: 35
Firm Overview & Performance
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+25.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
53%
566 W / 511 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
73%
479 W / 174 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
71 W / 582 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
5%
34 W / 619 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
53%
304 W / 266 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
52%
484 W / 441 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
54%
82 W / 70 L
Latest Price Targets
| Date | Stock | Signal | Analyst | Target | Start Price | Best Price (1Y) | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
SELL | - |
$55.00
Est. +4%
|
$57.35 | $36.07 (Low) |
$36.56
+36.3%
|
| Sep 15, 2026 |
Benitec Biopharma Inc
BNTC
|
BUY | - |
$17.00
Est. +45%
|
$11.73 | $12.11 |
$9.83
-16.2%
|
| Sep 15, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY | - |
$70.00
Est. +45%
|
$48.29 | $51.74 |
$49.85
+3.2%
|
| Sep 14, 2026 |
Roblox Corporation - Ordinary Shares - Class A
RBLX
|
BUY | - |
$48.00
Est. +5%
|
$45.50 | $51.96 |
$48.99
+7.7%
|
| Sep 10, 2026 |
Dynatrace Inc
DT
|
BUY | Steven Wahrhaftig |
$54.00
Est. +5%
|
$51.42 | $59.31 |
$58.51
+13.8%
|
| Sep 10, 2026 |
Check Point Software Technologies Ltd.
CHKP
|
BUY | - |
$135.00
Est. +3%
|
$130.51 | $141.96 |
$141.16
+8.2%
|
| Sep 10, 2026 |
Fortinet Inc
FTNT
|
SELL | - |
$155.00
Est. +2%
|
$158.85 | $154.00 (Low) |
$178.74
-12.5%
|
| Sep 10, 2026 |
Telos Corp
TLS
|
BUY | - |
$5.00
Est. +7%
|
$4.68 | $4.79 |
$4.09
-12.6%
|
| Sep 10, 2026 |
Qualys Inc
QLYS
|
BUY | - |
$175.00
Est. +8%
|
$161.57 | $186.93 |
$184.79
+14.4%
|
| Sep 10, 2026 |
Varonis Systems Inc
VRNS
|
BUY | - |
$46.00
Est. +1%
|
$45.50 | $48.76 |
$48.35
+6.3%
|
| Sep 10, 2026 |
Pyxis Oncology Inc
PYXS
|
BUY | Robert Driscoll |
$8.00
Est. +137%
|
$3.38 | $3.52 |
$3.22
-4.7%
|
| Sep 09, 2026 |
Pharvaris NV
PHVS
|
BUY | - |
$50.00
Est. +33%
|
$37.55 | $40.60 |
$33.07
-11.9%
|
| Sep 09, 2026 |
Intellia Therapeutics Inc
NTLA
|
BUY | David Nierengarten |
$13.00
Est. +3%
|
$12.64 | $12.98 |
$12.33
-2.5%
|
| Sep 03, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY | Laura Chico |
$23.00
Est. +56%
|
$14.79 | $16.11 |
$14.88
+0.6%
|
| Sep 03, 2026 |
Netapp Inc
NTAP
|
SELL | - |
$170.00
Est. +7%
|
$182.21 | $161.00 (Low) |
$196.33
-7.7%
|
| Sep 02, 2026 |
Tscan Therapeutics Inc
TCRX
|
BUY | - |
$1.00
Est. +150%
|
$0.40 | $0.57 |
$0.36
-9.0%
|
| Sep 01, 2026 |
Verisign Inc.
VRSN
|
BUY | - |
$341.00
Est. +18%
|
$288.28 | $309.40 |
$293.28
+1.7%
|
| Aug 26, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY | - |
$123.00
Est. +29%
|
$95.18 | $96.22 |
$88.17
-7.4%
|
| Aug 21, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY | - |
$64.00
Est. +14%
|
$55.97 | $61.75 |
$49.85
-10.9%
|
| Aug 20, 2026 |
Wix.com Ltd
WIX
|
BUY | - |
$80.00
Est. +1%
|
$79.06 | $96.79 |
$76.80
-2.9%
|
| Aug 20, 2026 |
Duolingo Inc - Ordinary Shares - Class A
DUOL
|
BUY | Ygal Arounian |
$150.00
Est. +2%
|
$146.62 | $167.34 |
$145.98
-0.4%
|
| Aug 20, 2026 |
Expedia Group Inc
EXPE
|
BUY | - |
$417.00
Est. +28%
|
$325.47 | $341.69 |
$259.04
-20.4%
|
| Aug 20, 2026 |
DoorDash Inc - Ordinary Shares - Class A
DASH
|
SELL | - |
$220.00
Est. +0%
|
$220.66 | $184.86 (Low) |
$189.27
+14.2%
|
| Aug 20, 2026 |
Criteo S.A - ADR
CRTO
|
BUY | - |
$25.00
Est. +41%
|
$17.77 | $18.46 |
$16.55
-6.9%
|
| Aug 20, 2026 |
EBay Inc.
EBAY
|
BUY | Ygal Arounian |
$137.00
Est. +31%
|
$104.51 | $113.63 |
$109.09
+4.4%
|
| Aug 19, 2026 |
Akoustis Technologies Inc
AKTS
|
BUY | David Nierengarten |
$35.00
Est. +40%
|
$25.00 | $27.66 |
$19.72
-21.1%
|
| Aug 18, 2026 |
Argen X SE - ADR
ARGX
|
BUY | - |
$1,150.00
Est. +16%
|
$987.84 | $1,072.75 |
$945.82
-4.3%
|
| Aug 17, 2026 |
Immunic Inc
IMUX
|
BUY | Martin Fan |
$45.00
Est. +180%
|
$16.06 | $17.18 |
$9.37
-41.7%
|
| Aug 14, 2026 |
Globant S.A.
GLOB
|
SELL | Steven Wahrhaftig |
$37.00
Est. +10%
|
$40.99 | $34.45 (Low) |
$34.45
+16.0%
|
| Aug 12, 2026 |
Fennec Pharmaceuticals Inc
FENC
|
BUY | - |
$16.00
Est. +35%
|
$11.88 | $12.80 |
$10.51
-11.5%
|
| Aug 12, 2026 |
Vor Biopharma Inc
VOR
|
BUY | - |
$27.00
Est. +18%
|
$22.92 | $26.02 |
$19.37
-15.5%
|
| Aug 12, 2026 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
BUY | - |
$33.00
Est. +39%
|
$23.76 | $25.24 |
$20.49
-13.8%
|
| Aug 12, 2026 |
Hemab Therapeutics Holdings, Inc. Common Stock
COAG
|
BUY | David Nierengarten |
$64.00
Est. +24%
|
$51.77 | $55.42 |
$36.73
-29.1%
|
| Aug 12, 2026 |
Super Micro Computer Inc
SMCI
|
BUY | Matt Bryson |
$40.00
Est. +12%
|
$35.82 | $42.70 |
$41.44
+15.7%
|
| Aug 12, 2026 |
Immunome Inc
IMNM
|
BUY | - |
$35.00
Est. +33%
|
$26.27 | $29.72 |
$24.24
-7.7%
|
| Aug 12, 2026 |
National Cinemedia Inc
NCMI
|
BUY | - |
$5.00
Est. +93%
|
$2.59 | $2.90 |
$2.20
-15.1%
|
| Aug 10, 2026 |
Protagonist Therapeutics Inc
PTGX
|
BUY | - |
$173.00
Est. +16%
|
$149.51 | $160.00 |
$138.70
-7.2%
|
| Aug 10, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY | Laura Chico |
$47.00
Est. +115%
|
$21.88 | $25.00 |
$14.71
-32.8%
|
| Aug 07, 2026 |
Airbnb Inc - Ordinary Shares - Class A
ABNB
|
BUY | - |
$200.00
Est. +32%
|
$151.64 | $193.45 |
$149.58
-1.4%
|
| Aug 07, 2026 |
Replimune Group Inc
REPL
|
BUY | Robert Driscoll |
$19.00
Est. +48%
|
$12.86 | $16.33 |
$12.96
+0.8%
|
| Aug 06, 2026 |
Applovin Corp - Ordinary Shares - Class A
APP
|
BUY | - |
$610.00
Est. +82%
|
$335.20 | $352.00 |
$315.25
-6.0%
|
| Aug 06, 2026 |
Arcus Biosciences Inc
RCUS
|
BUY | - |
$43.00
Est. +49%
|
$28.79 | $31.58 |
$26.39
-8.3%
|
| Aug 06, 2026 |
Revolution Medicines Inc
RVMD
|
SELL | - |
$201.00
Est. +0%
|
$201.90 | $188.22 (Low) |
$190.74
+5.5%
|
| Aug 06, 2026 |
TaskUs Inc - Ordinary Shares Class A
TASK
|
BUY | - |
$9.00
Est. +19%
|
$7.55 | $8.80 |
$8.41
+11.4%
|
| Aug 06, 2026 |
Flutter Entertainment Plc
FLUT
|
BUY | Matthew McCartney |
$126.00
Est. +37%
|
$91.80 | $104.84 |
$85.89
-6.4%
|
| Aug 06, 2026 |
Freedom Holding Corp
FRHC
|
BUY | - |
$180.00
Est. +20%
|
$150.01 | $177.36 |
$172.73
+15.1%
|
| Aug 05, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY | David Nierengarten |
$130.00
Est. +23%
|
$105.83 | $110.15 |
$88.17
-16.7%
|
| Aug 05, 2026 |
Larimar Therapeutics Inc
LRMR
|
BUY | - |
$11.00
Est. +160%
|
$4.23 | $4.47 |
$3.87
-8.6%
|
| Aug 05, 2026 |
Booking Holdings Inc
BKNG
|
BUY | Ygal Arounian |
$247.00
Est. +19%
|
$207.99 | $215.68 |
$155.90
-25.0%
|
| Aug 05, 2026 |
Ideaya Biosciences Inc
IDYA
|
BUY | - |
$60.00
Est. +66%
|
$36.11 | $42.68 |
$37.46
+3.7%
|
Xenon Pharmaceuticals Inc
XENE
Sep 18, 2026
Analyst
-
Signal & Target
SELL
$55.00
Start Price
$57.35
Best Price (1Y)
$36.07
Current Price
$36.56
Return
+36.3%
Benitec Biopharma Inc
BNTC
Sep 15, 2026
Analyst
-
Signal & Target
BUY
$17.00
Start Price
$11.73
Best Price (1Y)
$12.11
Current Price
$9.83
Return
-16.2%
Scholar Rock Holding Corp
SRRK
Sep 15, 2026
Analyst
-
Signal & Target
BUY
$70.00
Start Price
$48.29
Best Price (1Y)
$51.74
Current Price
$49.85
Return
+3.2%
Roblox Corporation - Ordinary Shares - Class A
RBLX
Sep 14, 2026
Analyst
-
Signal & Target
BUY
$48.00
Start Price
$45.50
Best Price (1Y)
$51.96
Current Price
$48.99
Return
+7.7%
Dynatrace Inc
DT
Sep 10, 2026
Analyst
Steven Wahrhaftig
Signal & Target
BUY
$54.00
Start Price
$51.42
Best Price (1Y)
$59.31
Current Price
$58.51
Return
+13.8%
Check Point Software Technologies Ltd.
CHKP
Sep 10, 2026
Analyst
-
Signal & Target
BUY
$135.00
Start Price
$130.51
Best Price (1Y)
$141.96
Current Price
$141.16
Return
+8.2%
Fortinet Inc
FTNT
Sep 10, 2026
Analyst
-
Signal & Target
SELL
$155.00
Start Price
$158.85
Best Price (1Y)
$154.00
Current Price
$178.74
Return
-12.5%
Telos Corp
TLS
Sep 10, 2026
Analyst
-
Signal & Target
BUY
$5.00
Start Price
$4.68
Best Price (1Y)
$4.79
Current Price
$4.09
Return
-12.6%
Qualys Inc
QLYS
Sep 10, 2026
Analyst
-
Signal & Target
BUY
$175.00
Start Price
$161.57
Best Price (1Y)
$186.93
Current Price
$184.79
Return
+14.4%
Varonis Systems Inc
VRNS
Sep 10, 2026
Analyst
-
Signal & Target
BUY
$46.00
Start Price
$45.50
Best Price (1Y)
$48.76
Current Price
$48.35
Return
+6.3%
Pyxis Oncology Inc
PYXS
Sep 10, 2026
Analyst
Robert Driscoll
Signal & Target
BUY
$8.00
Start Price
$3.38
Best Price (1Y)
$3.52
Current Price
$3.22
Return
-4.7%
Pharvaris NV
PHVS
Sep 09, 2026
Analyst
-
Signal & Target
BUY
$50.00
Start Price
$37.55
Best Price (1Y)
$40.60
Current Price
$33.07
Return
-11.9%
Intellia Therapeutics Inc
NTLA
Sep 09, 2026
Analyst
David Nierengarten
Signal & Target
BUY
$13.00
Start Price
$12.64
Best Price (1Y)
$12.98
Current Price
$12.33
Return
-2.5%
Ultragenyx Pharmaceutical Inc.
RARE
Sep 03, 2026
Analyst
Laura Chico
Signal & Target
BUY
$23.00
Start Price
$14.79
Best Price (1Y)
$16.11
Current Price
$14.88
Return
+0.6%
Netapp Inc
NTAP
Sep 03, 2026
Analyst
-
Signal & Target
SELL
$170.00
Start Price
$182.21
Best Price (1Y)
$161.00
Current Price
$196.33
Return
-7.7%
Tscan Therapeutics Inc
TCRX
Sep 02, 2026
Analyst
-
Signal & Target
BUY
$1.00
Start Price
$0.40
Best Price (1Y)
$0.57
Current Price
$0.36
Return
-9.0%
Verisign Inc.
VRSN
Sep 01, 2026
Analyst
-
Signal & Target
BUY
$341.00
Start Price
$288.28
Best Price (1Y)
$309.40
Current Price
$293.28
Return
+1.7%
Spyre Therapeutics Inc.
SYRE
Aug 26, 2026
Analyst
-
Signal & Target
BUY
$123.00
Start Price
$95.18
Best Price (1Y)
$96.22
Current Price
$88.17
Return
-7.4%
Scholar Rock Holding Corp
SRRK
Aug 21, 2026
Analyst
-
Signal & Target
BUY
$64.00
Start Price
$55.97
Best Price (1Y)
$61.75
Current Price
$49.85
Return
-10.9%
Wix.com Ltd
WIX
Aug 20, 2026
Analyst
-
Signal & Target
BUY
$80.00
Start Price
$79.06
Best Price (1Y)
$96.79
Current Price
$76.80
Return
-2.9%
Duolingo Inc - Ordinary Shares - Class A
DUOL
Aug 20, 2026
Analyst
Ygal Arounian
Signal & Target
BUY
$150.00
Start Price
$146.62
Best Price (1Y)
$167.34
Current Price
$145.98
Return
-0.4%
Expedia Group Inc
EXPE
Aug 20, 2026
Analyst
-
Signal & Target
BUY
$417.00
Start Price
$325.47
Best Price (1Y)
$341.69
Current Price
$259.04
Return
-20.4%
DoorDash Inc - Ordinary Shares - Class A
DASH
Aug 20, 2026
Analyst
-
Signal & Target
SELL
$220.00
Start Price
$220.66
Best Price (1Y)
$184.86
Current Price
$189.27
Return
+14.2%
Criteo S.A - ADR
CRTO
Aug 20, 2026
Analyst
-
Signal & Target
BUY
$25.00
Start Price
$17.77
Best Price (1Y)
$18.46
Current Price
$16.55
Return
-6.9%
EBay Inc.
EBAY
Aug 20, 2026
Analyst
Ygal Arounian
Signal & Target
BUY
$137.00
Start Price
$104.51
Best Price (1Y)
$113.63
Current Price
$109.09
Return
+4.4%
Akoustis Technologies Inc
AKTS
Aug 19, 2026
Analyst
David Nierengarten
Signal & Target
BUY
$35.00
Start Price
$25.00
Best Price (1Y)
$27.66
Current Price
$19.72
Return
-21.1%
Argen X SE - ADR
ARGX
Aug 18, 2026
Analyst
-
Signal & Target
BUY
$1,150.00
Start Price
$987.84
Best Price (1Y)
$1,072.75
Current Price
$945.82
Return
-4.3%
Immunic Inc
IMUX
Aug 17, 2026
Analyst
Martin Fan
Signal & Target
BUY
$45.00
Start Price
$16.06
Best Price (1Y)
$17.18
Current Price
$9.37
Return
-41.7%
Globant S.A.
GLOB
Aug 14, 2026
Analyst
Steven Wahrhaftig
Signal & Target
SELL
$37.00
Start Price
$40.99
Best Price (1Y)
$34.45
Current Price
$34.45
Return
+16.0%
Fennec Pharmaceuticals Inc
FENC
Aug 12, 2026
Analyst
-
Signal & Target
BUY
$16.00
Start Price
$11.88
Best Price (1Y)
$12.80
Current Price
$10.51
Return
-11.5%
Vor Biopharma Inc
VOR
Aug 12, 2026
Analyst
-
Signal & Target
BUY
$27.00
Start Price
$22.92
Best Price (1Y)
$26.02
Current Price
$19.37
Return
-15.5%
Bicara Therapeutics Inc. Common Stock
BCAX
Aug 12, 2026
Analyst
-
Signal & Target
BUY
$33.00
Start Price
$23.76
Best Price (1Y)
$25.24
Current Price
$20.49
Return
-13.8%
Hemab Therapeutics Holdings, Inc. Common Stock
COAG
Aug 12, 2026
Analyst
David Nierengarten
Signal & Target
BUY
$64.00
Start Price
$51.77
Best Price (1Y)
$55.42
Current Price
$36.73
Return
-29.1%
Super Micro Computer Inc
SMCI
Aug 12, 2026
Analyst
Matt Bryson
Signal & Target
BUY
$40.00
Start Price
$35.82
Best Price (1Y)
$42.70
Current Price
$41.44
Return
+15.7%
Immunome Inc
IMNM
Aug 12, 2026
Analyst
-
Signal & Target
BUY
$35.00
Start Price
$26.27
Best Price (1Y)
$29.72
Current Price
$24.24
Return
-7.7%
National Cinemedia Inc
NCMI
Aug 12, 2026
Analyst
-
Signal & Target
BUY
$5.00
Start Price
$2.59
Best Price (1Y)
$2.90
Current Price
$2.20
Return
-15.1%
Protagonist Therapeutics Inc
PTGX
Aug 10, 2026
Analyst
-
Signal & Target
BUY
$173.00
Start Price
$149.51
Best Price (1Y)
$160.00
Current Price
$138.70
Return
-7.2%
Jade Biosciences, Inc.
JBIO
Aug 10, 2026
Analyst
Laura Chico
Signal & Target
BUY
$47.00
Start Price
$21.88
Best Price (1Y)
$25.00
Current Price
$14.71
Return
-32.8%
Airbnb Inc - Ordinary Shares - Class A
ABNB
Aug 07, 2026
Analyst
-
Signal & Target
BUY
$200.00
Start Price
$151.64
Best Price (1Y)
$193.45
Current Price
$149.58
Return
-1.4%
Replimune Group Inc
REPL
Aug 07, 2026
Analyst
Robert Driscoll
Signal & Target
BUY
$19.00
Start Price
$12.86
Best Price (1Y)
$16.33
Current Price
$12.96
Return
+0.8%
Applovin Corp - Ordinary Shares - Class A
APP
Aug 06, 2026
Analyst
-
Signal & Target
BUY
$610.00
Start Price
$335.20
Best Price (1Y)
$352.00
Current Price
$315.25
Return
-6.0%
Arcus Biosciences Inc
RCUS
Aug 06, 2026
Analyst
-
Signal & Target
BUY
$43.00
Start Price
$28.79
Best Price (1Y)
$31.58
Current Price
$26.39
Return
-8.3%
Revolution Medicines Inc
RVMD
Aug 06, 2026
Analyst
-
Signal & Target
SELL
$201.00
Start Price
$201.90
Best Price (1Y)
$188.22
Current Price
$190.74
Return
+5.5%
TaskUs Inc - Ordinary Shares Class A
TASK
Aug 06, 2026
Analyst
-
Signal & Target
BUY
$9.00
Start Price
$7.55
Best Price (1Y)
$8.80
Current Price
$8.41
Return
+11.4%
Flutter Entertainment Plc
FLUT
Aug 06, 2026
Analyst
Matthew McCartney
Signal & Target
BUY
$126.00
Start Price
$91.80
Best Price (1Y)
$104.84
Current Price
$85.89
Return
-6.4%
Freedom Holding Corp
FRHC
Aug 06, 2026
Analyst
-
Signal & Target
BUY
$180.00
Start Price
$150.01
Best Price (1Y)
$177.36
Current Price
$172.73
Return
+15.1%
Spyre Therapeutics Inc.
SYRE
Aug 05, 2026
Analyst
David Nierengarten
Signal & Target
BUY
$130.00
Start Price
$105.83
Best Price (1Y)
$110.15
Current Price
$88.17
Return
-16.7%
Larimar Therapeutics Inc
LRMR
Aug 05, 2026
Analyst
-
Signal & Target
BUY
$11.00
Start Price
$4.23
Best Price (1Y)
$4.47
Current Price
$3.87
Return
-8.6%
Booking Holdings Inc
BKNG
Aug 05, 2026
Analyst
Ygal Arounian
Signal & Target
BUY
$247.00
Start Price
$207.99
Best Price (1Y)
$215.68
Current Price
$155.90
Return
-25.0%
Ideaya Biosciences Inc
IDYA
Aug 05, 2026
Analyst
-
Signal & Target
BUY
$60.00
Start Price
$36.11
Best Price (1Y)
$42.68
Current Price
$37.46
Return
+3.7%
Recent Upgrades / Downgrades
| Date | Stock | Action | From | To |
|---|---|---|---|---|
| Sep 15, 2026 |
Scholar Rock Holding Corp
SRRK
|
Hold | Outperform | Outperform |
| Sep 15, 2026 |
Benitec Biopharma Inc
BNTC
|
Hold | Outperform | Outperform |
| Sep 14, 2026 |
Roblox Corporation - Ordinary Shares - Class A
RBLX
|
Hold | Neutral | Neutral |
| Sep 11, 2026 |
NVIDIA Corp
NVDA
|
Downgrade | Outperform | Underperform |
| Sep 11, 2026 |
Meta Platforms Inc - Ordinary Shares - Class A
META
|
Hold | Neutral | Neutral |
| Sep 11, 2026 |
Copart, Inc.
CPRT
|
Downgrade | Neutral | |
| Sep 11, 2026 |
Telos Corp
TLS
|
Downgrade | Neutral | Underperform |
| Sep 10, 2026 |
Fortinet Inc
FTNT
|
Downgrade | Underperform | Neutral |
| Sep 10, 2026 |
Check Point Software Technologies Ltd.
CHKP
|
Downgrade | Outperform | Neutral |
| Sep 10, 2026 |
Pyxis Oncology Inc
PYXS
|
Hold | Outperform | Outperform |
| Sep 10, 2026 |
Telos Corp
TLS
|
Downgrade | Outperform | Neutral |
| Sep 10, 2026 |
Varonis Systems Inc
VRNS
|
Downgrade | Outperform | Neutral |
| Sep 10, 2026 |
Qualys Inc
QLYS
|
Downgrade | Outperform | Neutral |
| Sep 10, 2026 |
Tenable Holdings Inc
TENB
|
Downgrade | Outperform | Underperform |
| Sep 10, 2026 |
Dynatrace Inc
DT
|
Downgrade | Outperform | Neutral |
| Sep 09, 2026 |
Pharvaris NV
PHVS
|
Hold | Outperform | Outperform |
| Sep 09, 2026 |
Apple Inc
AAPL
|
Hold | Outperform | Outperform |
| Sep 09, 2026 |
Intellia Therapeutics Inc
NTLA
|
Hold | Neutral | Neutral |
| Sep 03, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
Hold | Neutral | Neutral |
| Sep 03, 2026 |
Netapp Inc
NTAP
|
Hold | Neutral | Neutral |
| Sep 02, 2026 |
Tscan Therapeutics Inc
TCRX
|
Downgrade | Buy | Neutral |
| Sep 01, 2026 |
Verisign Inc.
VRSN
|
Hold | Outperform | Outperform |
| Aug 24, 2026 |
Best Buy Co. Inc.
BBY
|
Hold | Buy | Buy |
| Aug 21, 2026 |
Scholar Rock Holding Corp
SRRK
|
Hold | Outperform | Outperform |
| Aug 20, 2026 |
Expedia Group Inc
EXPE
|
Hold | Outperform | Outperform |
| Aug 20, 2026 |
Duolingo Inc - Ordinary Shares - Class A
DUOL
|
Hold | Neutral | Neutral |
| Aug 20, 2026 |
DoorDash Inc - Ordinary Shares - Class A
DASH
|
Hold | Neutral | Neutral |
| Aug 20, 2026 |
EBay Inc.
EBAY
|
Hold | Outperform | Outperform |
| Aug 20, 2026 |
Wix.com Ltd
WIX
|
Hold | Neutral | Neutral |
| Aug 19, 2026 |
Akoustis Technologies Inc
AKTS
|
Initialise | Outperform | |
| Aug 18, 2026 |
Argen X SE - ADR
ARGX
|
Hold | Outperform | Outperform |
| Aug 17, 2026 |
Immunic Inc
IMUX
|
Initialise | Outperform | |
| Aug 14, 2026 |
Eikon Therapeutics, Inc. Common Stock
EIKN
|
Hold | Underperform | Underperform |
| Aug 14, 2026 |
Micron Technology Inc.
MU
|
Downgrade | Outperform | Neutral |
| Aug 14, 2026 |
Globant S.A.
GLOB
|
Downgrade | Outperform | Neutral |
| Aug 12, 2026 |
Fennec Pharmaceuticals Inc
FENC
|
Hold | Outperform | Outperform |
| Aug 12, 2026 |
Super Micro Computer Inc
SMCI
|
Hold | Neutral | Neutral |
| Aug 12, 2026 |
Vor Biopharma Inc
VOR
|
Hold | Neutral | Neutral |
| Aug 12, 2026 |
Immunome Inc
IMNM
|
Hold | Outperform | Outperform |
| Aug 12, 2026 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
Hold | Outperform | Outperform |
| Aug 12, 2026 |
Zura Bio Ltd - Ordinary Shares - Class A
ZURA
|
Hold | Outperform | Outperform |
| Aug 12, 2026 |
Hemab Therapeutics Holdings, Inc. Common Stock
COAG
|
Hold | Outperform | Outperform |
| Aug 10, 2026 |
Jade Biosciences, Inc.
JBIO
|
Hold | Outperform | Outperform |
| Aug 10, 2026 |
Protagonist Therapeutics Inc
PTGX
|
Hold | Outperform | Outperform |
| Aug 07, 2026 |
Airbnb Inc - Ordinary Shares - Class A
ABNB
|
Upgrade | Neutral | Outperform |
| Aug 07, 2026 |
Space Exploration Technologies Corp.
SPCX
|
Upgrade | Outperform | Outperform |
| Aug 06, 2026 |
Travere Therapeutics Inc
TVTX
|
Hold | Outperform | Outperform |
| Aug 06, 2026 |
Flutter Entertainment Plc
FLUT
|
Hold | Outperform | Outperform |
| Aug 06, 2026 |
Arcus Biosciences Inc
RCUS
|
Hold | Outperform | Outperform |
| Aug 05, 2026 |
Spyre Therapeutics Inc.
SYRE
|
Hold | Outperform | Outperform |
Action
Hold
From
Outperform
To
Outperform
Benitec Biopharma Inc
BNTC
Sep 15
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Neutral
To
Neutral
NVIDIA Corp
NVDA
Sep 11
Action
Downgrade
From
Outperform
To
Underperform
Action
Hold
From
Neutral
To
Neutral
Copart, Inc.
CPRT
Sep 11
Action
Downgrade
From
-
To
Neutral
Telos Corp
TLS
Sep 11
Action
Downgrade
From
Neutral
To
Underperform
Fortinet Inc
FTNT
Sep 10
Action
Downgrade
From
Underperform
To
Neutral
Action
Downgrade
From
Outperform
To
Neutral
Pyxis Oncology Inc
PYXS
Sep 10
Action
Hold
From
Outperform
To
Outperform
Telos Corp
TLS
Sep 10
Action
Downgrade
From
Outperform
To
Neutral
Varonis Systems Inc
VRNS
Sep 10
Action
Downgrade
From
Outperform
To
Neutral
Qualys Inc
QLYS
Sep 10
Action
Downgrade
From
Outperform
To
Neutral
Tenable Holdings Inc
TENB
Sep 10
Action
Downgrade
From
Outperform
To
Underperform
Dynatrace Inc
DT
Sep 10
Action
Downgrade
From
Outperform
To
Neutral
Pharvaris NV
PHVS
Sep 09
Action
Hold
From
Outperform
To
Outperform
Apple Inc
AAPL
Sep 09
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Neutral
To
Neutral
Action
Hold
From
Neutral
To
Neutral
Netapp Inc
NTAP
Sep 03
Action
Hold
From
Neutral
To
Neutral
Tscan Therapeutics Inc
TCRX
Sep 02
Action
Downgrade
From
Buy
To
Neutral
Verisign Inc.
VRSN
Sep 01
Action
Hold
From
Outperform
To
Outperform
Best Buy Co. Inc.
BBY
Aug 24
Action
Hold
From
Buy
To
Buy
Action
Hold
From
Outperform
To
Outperform
Expedia Group Inc
EXPE
Aug 20
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Neutral
To
Neutral
Action
Hold
From
Neutral
To
Neutral
EBay Inc.
EBAY
Aug 20
Action
Hold
From
Outperform
To
Outperform
Wix.com Ltd
WIX
Aug 20
Action
Hold
From
Neutral
To
Neutral
Action
Initialise
From
-
To
Outperform
Argen X SE - ADR
ARGX
Aug 18
Action
Hold
From
Outperform
To
Outperform
Immunic Inc
IMUX
Aug 17
Action
Initialise
From
-
To
Outperform
Action
Hold
From
Underperform
To
Underperform
Micron Technology Inc.
MU
Aug 14
Action
Downgrade
From
Outperform
To
Neutral
Globant S.A.
GLOB
Aug 14
Action
Downgrade
From
Outperform
To
Neutral
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Neutral
To
Neutral
Vor Biopharma Inc
VOR
Aug 12
Action
Hold
From
Neutral
To
Neutral
Immunome Inc
IMNM
Aug 12
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Jade Biosciences, Inc.
JBIO
Aug 10
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Action
Upgrade
From
Neutral
To
Outperform
Action
Upgrade
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Arcus Biosciences Inc
RCUS
Aug 06
Action
Hold
From
Outperform
To
Outperform
Spyre Therapeutics Inc.
SYRE
Aug 05
Action
Hold
From
Outperform
To
Outperform